On Jun. 25, 2025, in the midst of a multi-state measles outbreak, a poll by Harvard T.H. Chan…
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
On Jun. 17, 2025, Eli Lilly and Verve Therapeutics, a Boston-based clinical-stage company developing genetic medicines for cardiovascular…
On Jun. 12, 2025, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345),…
On Jun. 2, 2025, Sanofi and Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis…
On May 28, 2025, Moderna announced that it has received notice from the U.S. Department of Health and…
On May 23, 2025 a Boston University School of Public Health (BUSPH) led study revealed that there were…
On May 19, 2025, Prime Medicine announced positive initial data from the first patient dosed in its ongoing…
On May 19, 2025, researchers at the Broad Institute Ben Neale and Mark Daly are co-leading the study,…
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) had approved mRESVIA (mRNA-1345),…
On Sept. 26, 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department…
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On May 4, 2021, Moderna announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA including…
On Sept. 28, 2020, Tonix Pharmaceuticals announced that it had completed the purchase a 40,000 square foot facility…
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
On Apr. 29, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
On Apr. 27, 2018, AquaBounty Technologies announced that it had received approval from the U.S. Food and Drug…